CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Neurotrope, Inc.  (NTRP)
Other Ticker:  
 
 

NTRP's Income from Cont. Operations Growth by Quarter and Year

Neurotrope,'s Income from Cont. Operations results by quarter and year




NTRP Income from Cont. Operations (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - -3.74 -4.31 -3.59
III Quarter September - -3.17 -2.30 -2.19
II Quarter June - -2.12 -2.95 -2.13
I Quarter March 4.69 -1.99 -3.06 -2.53
FY   4.69 -11.02 -12.62 -10.44



NTRP Income from Cont. Operations first quarter 2019 Y/Y Growth Comment
Neurotrope, Inc. in the first quarter achieved Income from Cont. Operations of $ 4.69 millions compare to loss from continued operations recorded in same quarter a year ago.

According to the results reported in the first quarter, Neurotrope, Inc. achieved the best Income from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Neurotrope, Inc.' s Income from Cont. Operations no change of % ranks overall at the positon no. 0 in the first quarter.




NTRP Income from Cont. Operations ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Neurotrope,'s first quarter 2019 Income from Cont. Operations $ 4.69 millions NTRP's Income Statement
Neurotrope,'s first quarter 2018 Income from Cont. Operations $ -1.99 millions Quarterly NTRP's Income Statement
New: More NTRP's historic Income from Cont. Operations Growth >>


NTRP Income from Cont. Operations (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Neurotrope,'s Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NTRP's I. Quarter Q/Q Income from Cont. Operations Comment
This reversal of fortune I. Quarter 2019where Neurotrope, Inc. posted Income from Cont. Operations of $ 4.69 millions may is starting point of better business climet.Neurotrope, Inc. announced in the I. Quarter 2019 Income from Cont. Operations of $ 4.69 millions compare to loss from continued operations recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Neurotrope, Inc. achieved highest sequential Income from Cont. Operations growth. While Neurotrope,'s Income from Cont. Operations growth quarter on quarter, overall rank is 0.


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NTRP's I. Quarter Q/Q Income from Cont. Operations Comment
Improvement I. Quarter 2019where Neurotrope, Inc. published Income from Cont. Operations of $ 4.69 millions could be beginning of better business climet.Neurotrope, Inc. announced in the I. Quarter 2019 Income from Cont. Operations of $ 4.69 millions compare to loss from continued operations recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Neurotrope, Inc. achieved highest sequential Income from Cont. Operations growth. While Neurotrope,'s Income from Cont. Operations growth quarter on quarter, overall rank is 0.


Neurotrope,'s 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
12 Months Ending
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Income from Cont. Operations 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment
In the period, Neurotrope,'s cumulative trailing twelve month Income from Cont. Operations remained unchanged compare to the same period a year ago.

Neurotrope, Inc. achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment
In the period, Neurotrope,'s cumulative trailing twelve month Income from Cont. Operations remained unchanged compare to the same period a year ago.

Neurotrope, Inc. achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
NTRP's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for NTRP's Competitors
Income from Cont. Operations Growth for Neurotrope,'s Suppliers
Income from Cont. Operations Growth for NTRP's Customers

You may also want to know
NTRP's Annual Growth Rates NTRP's Profitability Ratios NTRP's Asset Turnover Ratio NTRP's Dividend Growth
NTRP's Roe NTRP's Valuation Ratios NTRP's Financial Strength Ratios NTRP's Dividend Payout Ratio
NTRP's Roa NTRP's Inventory Turnover Ratio NTRP's Growth Rates NTRP's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Mar 31 2019 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Mar 31 2019
Fresenius Medical Care Ag & Co. Kgaa -0.59 %$ -0.592 millions
Chemed Corp -0.73 %$ -0.731 millions
Regeneron Pharmaceuticals Inc -3.53 %$ -3.532 millions
Resmed Inc -4.28 %$ -4.276 millions
Quest Diagnostics Inc -6.88 %$ -6.878 millions
Stryker Corp -7.00 %$ -6.998 millions
Baxter International Inc -10.80 %$ -10.797 millions
Abbvie Inc. -11.75 %$ -11.750 millions
Amgen Inc. -13.80 %$ -13.804 millions
Lannett Co Inc -16.64 %$ -16.641 millions
Henry Schein Inc -17.06 %$ -17.060 millions
Surmodics Inc -17.73 %$ -17.731 millions
Perrigo Co Plc -20.92 %$ -20.916 millions
Pacific Health Care Organization Inc -21.30 %$ -21.296 millions
Phibro Animal Health Corp -25.16 %$ -25.156 millions
Quidel Corp -26.84 %$ -26.839 millions
Msa Safety Inc -28.05 %$ -28.049 millions
Molecular Templates, Inc. -29.22 %$ -29.217 millions
Surgery Partners, Inc. -31.71 %$ -31.707 millions
Davita Inc. -32.46 %$ -32.458 millions
Mednax, Inc. -34.33 %$ -34.330 millions
Exelixis, Inc. -34.60 %$ -34.596 millions
Myriad Genetics Inc -38.94 %$ -38.938 millions
American Shared Hospital Services -39.23 %$ -39.231 millions
Foamix Pharmaceuticals Ltd. -41.47 %$ -41.471 millions
Integrity Applications, Inc. -44.71 %$ -44.710 millions
Psychemedics Corp -49.88 %$ -49.880 millions
Inogen Inc -50.72 %$ -50.716 millions
Luminex Corp -51.27 %$ -51.273 millions
Jrsis Health Care Corp -52.80 %$ -52.804 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MDVP's Profile

Stock Price

MDVP's Financials

Business Description

Fundamentals

Charts & Quotes

MDVP's News

Suppliers

MDVP's Competitors

Customers & Markets

Economic Indicators

MDVP's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071